⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
IMFINZI® approved in the US as first and only perioperative immunotherapy for patients with early gastric and gastroesophageal cancers
businesswire.com
AZN
DAI
MRK
8MM Respiratory Syncytial Virus Prophylaxis Drug Forecast Report 2025: A $7.2 Billion Market by 2030, Prophylactic Options to Continue to Diversify Due to Strength of Late-stage Pipeline
globenewswire.com
AZN
ABBV
SNY
MRK
GSK
PFE
MRNA
Follicular Lymphoma Market Trends, Opportunities, Growth Challenges and Competitive Intelligence 2025-2035
globenewswire.com
MRK
AZN
CRSP
BGNE
NKTR
ALKS
XNNY
BMY
Human Growth Hormone Injection Market Size Expected to Reach USD 8.54 Bn by 2035
globenewswire.com
PFE
MRK
LLY
ASND
IPN
Antitumor ADC Drugs Market Forecast Shows Strong 12.86% CAGR Through 2035
globenewswire.com
PFE
AZN
DSNKY
GILD
IMMU
REGN
BIIB
BMY
MRK
NVS
AMGN
LLY
JNJ
ABBV
BNTX
SEGN
RHHBY
Takeda
IQV
PE
CD38-Targeted Immunotherapies Pipeline and Competitive Intelligence Report 2025: Darzalex Became the Number 4 Blockbuster Biologic, Just Behind Keytruda, Dupixent and Skyrizi
globenewswire.com
MRK
SNY
REGN
Hidradenitis Suppurativa Market Opportunity Forecast Report 2025: 7MM Market to Reach $7.8 Billion by 2034, Driven by New Biologics and Small-Molecule Launches Including Sonelokimab and Povorcitinib
globenewswire.com
ABBV
INCY
JNJ
MRK
NVS
SNY
Chemotherapy-induced Peripheral Neuropathy Treatment Market Poised for Strong Growth Throughout the Forecast Period (2025–2034) Amid Rising Chemotherapy Adoption | DelveInsight
globenewswire.com
WEX
ATX
ASMF
VELO
WSNT
LEX
VRTX
PFE
REGN
LLY
GSK
NVO
ISPC
MRK
SCIX
DNA Damaging Agents Market Grows at 11.67% CAGR, to Hit USD 46.31 Billion by 2034
globenewswire.com
XRAY
NVS
RUC
NIRA
TLZ
AZN
BMY
MRK
Merck to Participate in the Citi 2025 Global Healthcare Conference
businesswire.com
MRK